Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Amyotrophic lateral sclerosis (ALS) (mmu05014)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1500003O
03Rik
KLA  ATP  ATP+KLA
 NM_019769 RIKEN cDNA 1500003O03 gene (1500003O03Rik), mRNA [NM_019769] KLA .92 .89 .89 .86 .85 .92 1.08
ATP 1.01 1.16 1.16 1.53 1.70 3.33 2.09
KLA/ATP .89 .97 .93 1.17 1.19 2.86 2.57
2010110P
09Rik
KLA  ATP  ATP+KLA
 NM_027363 RIKEN cDNA 2010110P09 gene (2010110P09Rik), mRNA [NM_027363] KLA .99 .98 1.02 .99 .94 1.01 1.01
ATP 1.04 1.05 .97 1.05 .95 .98 .95
KLA/ATP .93 1.00 1.02 .97 1.01 .96 .97
AK036998
KLA  ATP  ATP+KLA
 AK036998 adult female vagina cDNA, RIKEN full-length enriched library, clone:9930034M05 product:unclassifiable, full insert sequence. [AK036998] KLA 1.43 1.09 .89 .79 .96 .97 .71
ATP 1.04 1.04 .71 .64 .90 .82 .82
KLA/ATP 1.34 1.23 1.01 .89 1.10 .82 .75
AK042598
KLA  ATP  ATP+KLA
 AK042598 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730009A11 product:neurofilament, medium polypeptide, full insert sequence. [AK042598] KLA 1.00 1.04 .98 1.06 .97 .99 1.04
ATP 1.04 1.00 1.01 1.00 1.00 1.01 1.03
KLA/ATP .98 .98 1.02 1.01 1.00 1.05 1.00
Als2
KLA  ATP  ATP+KLA
 NM_028717 amyotrophic lateral sclerosis 2 (juvenile) homolog (human) (Als2), mRNA [NM_028717] KLA .89 .89 .97 .90 .94 1.10 1.16
ATP 1.00 .89 .65 .62 1.06 1.47 1.84
KLA/ATP .93 .87 .77 .62 .77 1.39 1.83
Apaf1
KLA  ATP  ATP+KLA
 NM_001042558 apoptotic peptidase activating factor 1 (Apaf1), transcript variant 1, mRNA [NM_001042558] KLA 2.92 2.81 3.22 2.74 2.42 1.74 1.40
ATP 1.05 .99 .87 .81 1.61 2.03 1.46
KLA/ATP 2.90 2.78 2.01 1.69 1.56 2.77 2.73
BC038887
KLA  ATP  ATP+KLA
 BC038887 translocase of outer mitochondrial membrane 40 homolog (yeast), mRNA (cDNA clone MGC:48245 IMAGE:3326417), complete cds. [BC038887] KLA .93 .95 .93 .89 .84 .97 1.00
ATP .96 .97 .96 .94 .90 .96 .94
KLA/ATP .97 1.01 .93 .99 .86 .87 .89
Bad
KLA  ATP  ATP+KLA
 AK029400 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4833429M11 product:Bcl-associated death promoter, full insert sequence. [AK029400] KLA 1.15 1.22 1.26 1.31 1.40 1.67 1.59
ATP .95 1.06 1.12 1.06 .78 .89 1.27
KLA/ATP 1.25 1.39 1.33 1.29 1.11 .91 1.38
Bax
KLA  ATP  ATP+KLA
 NM_007527 Bcl2-associated X protein (Bax), mRNA [NM_007527] KLA 1.08 1.14 1.10 1.14 1.17 1.06 .92
ATP 1.06 1.05 1.02 1.25 1.26 .90 .86
KLA/ATP 1.11 1.19 1.30 1.34 1.34 .87 .71
Bcl2
KLA  ATP  ATP+KLA
 NM_009741 B-cell leukemia/lymphoma 2 (Bcl2), transcript variant 1, mRNA [NM_009741] KLA .30 .26 .25 .25 .34 .38 .26
ATP .97 .89 1.50 1.04 .99 .29 .52
KLA/ATP .28 .26 .40 .33 .62 .29 .12
Bcl2
KLA  ATP  ATP+KLA
 NM_177410 B-cell leukemia/lymphoma 2 (Bcl2), transcript variant 2, mRNA [NM_177410] KLA .33 .33 .37 .42 .49 .46 .39
ATP 1.07 1.12 1.22 1.56 1.00 .38 .76
KLA/ATP .35 .34 .54 .89 .76 .36 .23
Bcl2l1
KLA  ATP  ATP+KLA
 NM_009743 Bcl2-like 1 (Bcl2l1), nuclear gene encoding mitochondrial protein, mRNA [NM_009743] KLA .99 1.02 1.10 1.16 1.27 .97 1.05
ATP 1.18 1.42 .81 1.26 1.51 .71 1.67
KLA/ATP 1.21 1.30 .66 1.15 1.31 1.17 1.59
Bid
KLA  ATP  ATP+KLA
 NM_007544 BH3 interacting domain death agonist (Bid), mRNA [NM_007544] KLA 1.03 1.08 1.09 1.14 1.01 .99 .68
ATP 1.06 1.11 .97 .89 1.04 1.17 1.08
KLA/ATP .88 1.09 .92 1.06 1.16 1.28 1.56
Casp1
KLA  ATP  ATP+KLA
 NM_009807 caspase 1 (Casp1), mRNA [NM_009807] KLA 4.27 4.63 5.39 6.07 5.87 5.49 2.96
ATP .93 .87 1.01 .80 1.05 3.11 2.77
KLA/ATP 4.31 4.18 5.40 4.00 4.66 4.90 7.20
Casp12
KLA  ATP  ATP+KLA
 NM_009808 caspase 12 (Casp12), mRNA [NM_009808] KLA 6.56 6.38 7.54 6.85 5.36 2.61 1.46
ATP .99 .98 1.17 1.56 1.32 1.40 1.13
KLA/ATP 6.27 6.52 5.79 5.68 3.74 2.21 1.78
Casp3
KLA  ATP  ATP+KLA
 NM_009810 caspase 3 (Casp3), mRNA [NM_009810] KLA 1.66 1.94 2.47 2.61 3.01 2.96 1.44
ATP .90 .99 1.17 1.30 1.01 1.17 .86
KLA/ATP 1.55 1.87 2.40 2.35 2.27 2.84 2.52
Casp3
KLA  ATP  ATP+KLA
 U49929 ICE-like cysteine protease (Lice) mRNA, complete cds. [U49929] KLA 1.71 1.87 2.69 3.11 3.64 3.42 1.52
ATP 1.04 1.07 1.16 1.34 .98 1.27 .86
KLA/ATP 1.80 1.96 2.46 2.91 2.50 3.24 3.10
Casp9
KLA  ATP  ATP+KLA
 NM_015733 caspase 9 (Casp9), mRNA [NM_015733] KLA .31 .31 .40 .66 .89 1.19 .91
ATP .88 .77 .91 .59 .43 .75 .93
KLA/ATP .26 .26 .30 .28 .80 1.06 .97
Cat
KLA  ATP  ATP+KLA
 NM_009804 catalase (Cat), mRNA [NM_009804] KLA .63 .67 .67 .45 .36 .21 .43
ATP 1.10 1.25 .91 1.01 .78 1.28 .84
KLA/ATP .75 .69 .43 .59 .35 .72 .87
Ccs
KLA  ATP  ATP+KLA
 NM_016892 copper chaperone for superoxide dismutase (Ccs), mRNA [NM_016892] KLA .95 .91 .93 .87 .81 .73 .72
ATP 1.07 .95 1.14 1.17 .96 .59 .79
KLA/ATP .96 .97 1.19 1.06 .94 .62 .54
Cycs
KLA  ATP  ATP+KLA
 NM_007808 cytochrome c, somatic (Cycs), nuclear gene encoding mitochondrial protein, mRNA [NM_007808] KLA 2.20 2.21 2.35 2.69 2.62 3.22 2.14
ATP .87 .89 1.31 1.05 1.06 1.20 1.26
KLA/ATP 1.88 2.04 2.86 2.26 2.57 2.45 2.03
Cyct
KLA  ATP  ATP+KLA
 NM_009989 cytochrome c, testis (Cyct), mRNA [NM_009989] KLA .93 1.01 1.00 .99 1.02 1.03 .96
ATP 1.01 .91 1.01 .99 .98 .95 .95
KLA/ATP 1.10 .96 .89 .89 1.10 1.05 .97
Daxx
KLA  ATP  ATP+KLA
 NM_007829 Fas death domain-associated protein (Daxx), mRNA [NM_007829] KLA 13.43 12.31 10.74 10.71 8.02 8.78 4.52
ATP .88 .79 .74 .47 1.05 5.31 2.46
KLA/ATP 11.40 11.89 13.01 10.51 12.32 11.59 9.74
Derl1
KLA  ATP  ATP+KLA
 NM_024207 Der1-like domain family, member 1 (Derl1), mRNA [NM_024207] KLA .86 .83 .81 .86 .93 1.11 1.45
ATP 1.06 1.09 1.13 1.07 1.09 1.24 1.72
KLA/ATP .80 .82 .92 .87 .89 1.15 1.99
Gpx1
KLA  ATP  ATP+KLA
 NM_008160 glutathione peroxidase 1 (Gpx1), mRNA [NM_008160] KLA .63 .68 .67 .51 .52 .48 .64
ATP 1.02 1.01 .85 .91 .66 .41 .97
KLA/ATP .76 .73 .47 .61 .45 .39 .70
Gria1
KLA  ATP  ATP+KLA
 NM_008165 glutamate receptor, ionotropic, AMPA1 (alpha 1) (Gria1), transcript variant 2, mRNA [NM_008165] KLA .97 1.02 1.02 1.01 1.03 1.02 1.11
ATP 1.03 .97 1.05 1.03 1.01 1.01 1.01
KLA/ATP 1.02 .99 1.01 1.06 1.15 1.06 1.05
Gria2
KLA  ATP  ATP+KLA
 BC048248 glutamate receptor, ionotropic, AMPA2 (alpha 2), mRNA (cDNA clone MGC:54603 IMAGE:6494013), complete cds. [BC048248] KLA 1.00 1.01 1.05 1.00 1.03 .97 1.06
ATP .98 1.00 1.00 .96 1.03 1.05 1.04
KLA/ATP .98 1.08 .99 1.04 1.06 1.02 1.05
Gria2
KLA  ATP  ATP+KLA
 NM_013540 glutamate receptor, ionotropic, AMPA2 (alpha 2) (Gria2), transcript variant 2, mRNA [NM_013540] KLA 1.02 1.02 .98 1.01 .98 1.02 1.01
ATP .95 1.01 .95 .99 1.09 1.02 1.09
KLA/ATP 1.06 .92 .96 .99 1.00 1.03 1.00
Grin1
KLA  ATP  ATP+KLA
 NM_008169 glutamate receptor, ionotropic, NMDA1 (zeta 1) (Grin1), mRNA [NM_008169] KLA .90 .97 .91 .98 .93 .94 1.01
ATP 1.04 1.04 1.02 1.08 .96 .91 .93
KLA/ATP .90 .99 .95 .95 .94 .88 .89
Grin2a
KLA  ATP  ATP+KLA
 NM_008170 glutamate receptor, ionotropic, NMDA2A (epsilon 1) (Grin2a), mRNA [NM_008170] KLA 1.00 1.08 1.00 1.03 1.09 1.02 1.04
ATP .96 .94 1.00 .98 1.03 .97 1.01
KLA/ATP .95 1.02 1.03 .95 .99 .99 .95
Grin2b
KLA  ATP  ATP+KLA
 NM_008171 glutamate receptor, ionotropic, NMDA2B (epsilon 2) (Grin2b), mRNA [NM_008171] KLA 1.03 1.02 1.10 1.09 1.02 1.03 1.08
ATP 1.15 1.07 1.05 1.07 1.08 1.04 1.02
KLA/ATP 1.10 1.04 1.07 1.13 1.09 1.08 1.06
Grin2c
KLA  ATP  ATP+KLA
 NM_010350 glutamate receptor, ionotropic, NMDA2C (epsilon 3) (Grin2c), mRNA [NM_010350] KLA 1.09 1.13 1.19 1.24 1.14 1.15 1.09
ATP 1.05 .96 .98 .98 .94 1.01 1.10
KLA/ATP 1.08 1.14 1.09 1.05 1.05 .98 1.01
Grin2d
KLA  ATP  ATP+KLA
 NM_008172 glutamate receptor, ionotropic, NMDA2D (epsilon 4) (Grin2d), mRNA [NM_008172] KLA 1.57 1.18 1.35 1.45 1.25 1.49 .91
ATP .92 .99 1.45 1.66 1.54 2.02 1.15
KLA/ATP 1.23 1.38 2.08 2.28 1.92 2.53 1.92
Map2k3
KLA  ATP  ATP+KLA
 NM_008928 mitogen-activated protein kinase kinase 3 (Map2k3), mRNA [NM_008928] KLA .88 .88 .73 .65 .99 1.34 .92
ATP 1.04 1.09 .89 1.62 1.93 1.75 1.17
KLA/ATP 1.00 .92 .66 1.21 1.80 2.24 2.10
Map2k6
KLA  ATP  ATP+KLA
 NM_011943 mitogen-activated protein kinase kinase 6 (Map2k6), mRNA [NM_011943] KLA .68 .67 .64 .67 .62 .59 .61
ATP 1.02 1.12 1.04 1.10 .79 .61 .61
KLA/ATP .73 .69 .71 .74 .66 .62 .98
Map3k5
KLA  ATP  ATP+KLA
 NM_008580 mitogen-activated protein kinase kinase kinase 5 (Map3k5), mRNA [NM_008580] KLA 1.85 1.97 1.17 .82 .57 .47 .49
ATP 1.06 1.05 .94 1.22 1.55 .91 .32
KLA/ATP 2.00 1.82 .95 .91 .60 .34 .28
Mapk11
KLA  ATP  ATP+KLA
 NM_011161 mitogen-activated protein kinase 11 (Mapk11), mRNA [NM_011161] KLA 1.28 1.30 1.41 1.46 1.58 1.29 .98
ATP .96 .95 .89 .82 .79 1.09 .85
KLA/ATP 1.44 1.42 1.32 1.23 1.23 .74 .66
Mapk12
KLA  ATP  ATP+KLA
 NM_013871 mitogen-activated protein kinase 12 (Mapk12), mRNA [NM_013871] KLA .94 .86 .87 .81 .77 .68 .49
ATP .97 .83 .92 .90 .86 .90 .51
KLA/ATP .91 .89 .88 .85 1.12 1.14 .53
Mapk13
KLA  ATP  ATP+KLA
 NM_011950 mitogen-activated protein kinase 13 (Mapk13), mRNA [NM_011950] KLA 1.22 1.21 1.35 1.26 1.24 1.13 1.01
ATP 1.08 1.00 1.20 1.20 1.13 1.22 1.39
KLA/ATP 1.22 1.27 1.30 1.30 1.21 1.11 1.47
Mapk14
KLA  ATP  ATP+KLA
 NM_011951 mitogen-activated protein kinase 14 (Mapk14), mRNA [NM_011951] KLA .70 .70 .62 .54 .67 .88 1.11
ATP 1.03 .98 .87 .69 .48 .78 .66
KLA/ATP .74 .68 .52 .46 .38 .45 .62
Mm.27970
KLA  ATP  ATP+KLA
 13994135 Unknown KLA 1.06 1.11 1.16 1.07 1.11 1.08 .95
ATP 1.02 1.09 1.05 1.05 .94 1.16 1.32
KLA/ATP 1.10 1.19 1.11 1.04 1.08 1.02 1.33
Mm.32259
4
KLA  ATP  ATP+KLA
 144922605 Unknown KLA 1.02 1.03 .98 .98 .95 1.00 1.02
ATP 1.01 .98 1.08 1.01 1.04 1.01 .97
KLA/ATP .97 1.08 1.04 1.02 1.00 1.01 1.03
Mm.33138
9
KLA  ATP  ATP+KLA
 158508469 Unknown KLA .80 .79 .81 .82 .72 .64 .50
ATP .95 .85 .56 .48 .30 .33 .46
KLA/ATP .71 .64 .50 .41 .33 .32 .42
Mm.42163
KLA  ATP  ATP+KLA
 157951683 Unknown KLA 1.15 1.26 1.21 1.33 1.13 1.06 .99
ATP 1.07 1.05 1.10 1.32 1.03 1.01 1.00
KLA/ATP 1.19 1.16 1.15 1.47 1.11 1.12 .96
Mm.4387
KLA  ATP  ATP+KLA
 133892666 Unknown KLA .85 .87 .85 .89 .77 .91 1.18
ATP 1.01 1.01 .87 1.07 .75 .86 .93
KLA/ATP .88 .86 .77 .81 .72 .91 .84
Nefh
KLA  ATP  ATP+KLA
 NM_010904 neurofilament, heavy polypeptide (Nefh), mRNA [NM_010904] KLA .98 1.00 .95 .98 .96 .99 .96
ATP .97 1.01 1.03 1.03 .98 1.02 .99
KLA/ATP 1.04 .93 .94 1.01 .94 .98 .97
Nefl
KLA  ATP  ATP+KLA
 AK149219 2 days neonate sympathetic ganglion cDNA, RIKEN full-length enriched library, clone:7120495C04 product:neurofilament, light polypeptide, full insert sequence [AK149219] KLA .96 1.05 1.01 1.02 1.01 .98 .98
ATP 1.04 1.05 1.03 1.02 .96 1.02 .97
KLA/ATP 1.05 .96 1.11 1.03 1.00 1.06 .99
Nefl
KLA  ATP  ATP+KLA
 NM_010910 neurofilament, light polypeptide (Nefl), mRNA [NM_010910] KLA .93 1.01 .94 1.07 .98 .94 1.03
ATP 1.01 .98 .99 .98 .98 .97 .93
KLA/ATP 1.00 .92 .94 .97 .97 1.03 .92
Nefm
KLA  ATP  ATP+KLA
 NM_008691 neurofilament, medium polypeptide (Nefm), mRNA [NM_008691] KLA 1.02 .99 1.01 1.01 1.02 .99 1.00
ATP 1.04 1.01 1.01 1.08 1.10 1.06 .99
KLA/ATP 1.02 1.01 1.04 1.04 1.02 1.03 .99
Nos1
KLA  ATP  ATP+KLA
 NM_008712 nitric oxide synthase 1, neuronal (Nos1), mRNA [NM_008712] KLA 1.01 1.01 1.02 .99 1.02 1.02 1.01
ATP 1.01 1.03 1.02 1.04 1.03 1.01 1.00
KLA/ATP 1.05 1.02 1.02 1.00 1.02 1.03 1.03
Ppp3ca
KLA  ATP  ATP+KLA
 NM_008913 protein phosphatase 3, catalytic subunit, alpha isoform (Ppp3ca), mRNA [NM_008913] KLA .76 .85 .81 .85 .73 .70 .52
ATP .96 .78 .55 .46 .31 .33 .48
KLA/ATP .74 .64 .52 .42 .37 .36 .45
Ppp3cb
KLA  ATP  ATP+KLA
 AK135203 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720421K10 product:protein phosphatase 3, catalytic subunit, beta isoform, full insert sequence. [AK135203] KLA 1.74 1.57 1.91 1.59 1.47 1.26 1.40
ATP 1.17 1.03 1.30 1.00 .81 .62 1.37
KLA/ATP 1.68 1.70 1.91 1.37 1.09 .47 1.13
Ppp3cb
KLA  ATP  ATP+KLA
 AK171904 activated spleen cDNA, RIKEN full-length enriched library, clone:F830018L06 product:Protein phosphatase 3 catalytic subunit beta3 (EC 3.1.3.16) (Serine [AK171904] KLA 1.29 1.29 1.21 1.15 1.22 1.13 1.28
ATP .90 .86 .80 .98 .94 .73 .92
KLA/ATP 1.06 1.03 .77 1.04 .92 .68 .90
Ppp3cb
KLA  ATP  ATP+KLA
 NM_008914 protein phosphatase 3, catalytic subunit, beta isoform (Ppp3cb), mRNA [NM_008914] KLA 1.21 1.29 1.38 1.24 1.29 1.08 1.23
ATP 1.15 1.31 1.09 1.29 .86 .60 .64
KLA/ATP 1.33 1.40 1.04 1.28 .79 .58 .73
Ppp3cc
KLA  ATP  ATP+KLA
 AK037563 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130026K22 product:unclassifiable, full insert sequence [AK037563] KLA 1.27 1.18 1.21 1.15 1.01 .92 1.36
ATP .96 1.09 1.10 1.03 .85 1.06 1.47
KLA/ATP 1.17 1.24 1.07 1.13 .91 .88 1.36
Ppp3cc
KLA  ATP  ATP+KLA
 NM_008915 protein phosphatase 3, catalytic subunit, gamma isoform (Ppp3cc), mRNA [NM_008915] KLA 1.64 1.81 1.79 1.35 .90 .70 1.31
ATP .90 .90 1.13 .93 .86 1.40 1.60
KLA/ATP 1.45 1.62 1.74 1.47 1.04 1.01 1.31
Ppp3r1
KLA  ATP  ATP+KLA
 NM_024459 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) (Ppp3r1), mRNA [NM_024459] KLA 1.02 1.17 .93 1.27 1.15 1.30 1.30
ATP .97 .95 .77 .91 .99 1.18 1.10
KLA/ATP 1.12 1.04 .88 1.00 1.10 1.10 1.07
Ppp3r2
KLA  ATP  ATP+KLA
 NM_001004025 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type II) (Ppp3r2), mRNA [NM_001004025] KLA 1.03 1.05 1.06 1.08 1.12 1.05 1.04
ATP 1.00 1.02 1.04 1.04 .99 .99 1.01
KLA/ATP 1.04 1.12 1.03 1.09 1.00 .99 1.00
Prph
KLA  ATP  ATP+KLA
 NM_013639 peripherin (Prph), mRNA [NM_013639] KLA .97 1.02 1.00 .98 .97 .92 .91
ATP .96 1.20 1.01 1.06 1.13 .95 .96
KLA/ATP .95 .96 1.02 .97 1.02 1.00 .96
Prph2
KLA  ATP  ATP+KLA
 NM_008938 peripherin 2 (Prph2), mRNA [NM_008938] KLA 1.01 .99 .99 .97 1.04 1.03 1.14
ATP 1.04 1.08 1.01 1.02 1.05 1.05 1.11
KLA/ATP 1.03 .98 .99 1.15 .98 1.05 .97
Rab5a
KLA  ATP  ATP+KLA
 AK036011 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630027A13 product:hypothetical protein, full insert sequence. [AK036011] KLA .98 1.01 .98 .93 1.04 .95 1.02
ATP 1.01 1.02 1.03 .96 1.08 1.04 1.08
KLA/ATP 1.06 1.02 1.02 .92 .99 1.01 1.08
Rab5a
KLA  ATP  ATP+KLA
 NM_025887 RAB5A, member RAS oncogene family (Rab5a), mRNA [NM_025887] KLA 1.88 1.84 2.12 2.01 1.68 1.40 1.18
ATP 1.00 .95 .93 .81 1.10 1.57 1.09
KLA/ATP 1.87 1.86 1.87 1.72 1.71 1.63 1.47
Rac1
KLA  ATP  ATP+KLA
 NM_009007 RAS-related C3 botulinum substrate 1 (Rac1), mRNA [NM_009007] KLA 1.02 1.01 1.02 .99 1.03 1.15 1.08
ATP .99 1.15 1.01 1.27 1.06 1.20 1.06
KLA/ATP 1.00 1.04 .88 1.16 .91 1.21 1.38
Slc1a2
KLA  ATP  ATP+KLA
 NM_001077514 solute carrier family 1 (glial high affinity glutamate transporter), member 2 (Slc1a2), transcript variant 1, mRNA [NM_001077514] KLA 1.07 1.09 1.17 1.09 1.16 1.09 1.05
ATP 1.06 .99 .99 1.01 1.08 1.22 1.19
KLA/ATP 1.10 1.10 1.10 1.06 1.12 1.16 1.28
Slc1a2
KLA  ATP  ATP+KLA
 NM_011393 solute carrier family 1 (glial high affinity glutamate transporter), member 2 (Slc1a2), transcript variant 3, mRNA [NM_011393] KLA 1.07 1.07 1.01 1.12 1.12 1.21 1.12
ATP .96 1.01 1.02 1.09 1.10 1.21 1.22
KLA/ATP 1.05 1.12 1.06 1.02 1.18 1.22 1.36
Sod1
KLA  ATP  ATP+KLA
 AK080908 4 days neonate male adipose cDNA, RIKEN full-length enriched library, clone:B430204E11 product:superoxide dismutase 1, soluble, full insert sequence [AK080908] KLA .70 .66 .60 .58 .66 .71 .86
ATP .93 .82 .78 .90 1.22 .91 .84
KLA/ATP .66 .64 .71 .75 .74 .73 .77
Sod1
KLA  ATP  ATP+KLA
 NM_011434 superoxide dismutase 1, soluble (Sod1), mRNA [NM_011434] KLA .71 .80 .65 .90 .69 .53 .53
ATP 1.03 .84 1.06 .96 1.27 1.34 .66
KLA/ATP .78 .79 1.12 .77 .96 .82 .52
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07
Tnfrsf1a
KLA  ATP  ATP+KLA
 NM_011609 tumor necrosis factor receptor superfamily, member 1a (Tnfrsf1a), mRNA [NM_011609] KLA 1.74 1.71 1.90 2.16 1.95 1.74 1.16
ATP .95 .83 .55 .41 .41 1.55 1.32
KLA/ATP 1.58 1.49 1.19 1.03 .98 2.02 2.10
Tnfrsf1b
KLA  ATP  ATP+KLA
 NM_011610 tumor necrosis factor receptor superfamily, member 1b (Tnfrsf1b), mRNA [NM_011610] KLA 9.07 9.05 8.93 10.89 10.14 11.61 6.74
ATP .98 .95 1.03 1.55 5.28 11.41 3.60
KLA/ATP 7.95 8.55 9.86 8.13 7.80 9.94 18.02
Tomm40
KLA  ATP  ATP+KLA
 NM_016871 translocase of outer mitochondrial membrane 40 homolog (yeast) (Tomm40), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_016871] KLA 1.08 1.11 1.11 .94 .94 .88 1.25
ATP 1.01 1.18 1.01 1.50 .99 .71 .86
KLA/ATP 1.22 1.30 .90 1.39 .78 .55 .52
Tomm40l
KLA  ATP  ATP+KLA
 NM_001037170 translocase of outer mitochondrial membrane 40 homolog-like (yeast) (Tomm40l), nuclear gene encoding mitochondrial protein, mRNA [NM_001037170] KLA .81 .75 .77 .80 .65 .52 .75
ATP 1.08 1.00 .85 .97 .53 .35 .78
KLA/ATP .84 .80 .71 .73 .54 .35 .53
Trp53
KLA  ATP  ATP+KLA
 NM_011640 transformation related protein 53 (Trp53), mRNA [NM_011640] KLA 1.25 1.37 1.11 .86 .72 .71 .95
ATP 1.15 1.32 .90 1.85 1.26 .68 .70
KLA/ATP 1.66 1.49 .80 1.76 .81 .65 .74